KRISTINA WILLHITE: Open Payments
NPI 1568174308 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 44 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $385 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $229 |
| Otsuka America Pharmaceutical, Inc. | 9 | $137 |
| Novo Nordisk Inc | 5 | $107 |
| ABBVIE INC. | 4 | $83 |
| Lilly USA, LLC | 4 | $76 |
| PFIZER INC. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Dynavax Technologies Corporation | 3 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: Veozah, REXULTI, PREVNAR 20, Kerendia, UBRELVY, Ozempic, MOUNJARO, Saxenda.
Industry payments across TN — which companies pay providers there.
